...background knowledge of the pharma organization. We also have the ability to reach into our Millipore...

...Merck’s Merck Millipore business will provide its Provantage End-to-End services for the development and manufacturing of...
...biosimilar pipeline, beginning with biosimilars for non-small cell lung cancer (NSCLC) and rheumatoid arthritis (RA). Millipore...

...posted revenues of $2.7 billion in 2013. Merck said the acquisition would complement its EMD Millipore...

...of R&D in the interim Promoted: Udit Batra to president and CEO of Merck's EMD Millipore...

...of the pharma's consumer health division, was promoted to president and CEO of Merck's EMD Millipore...

...Merck's EMD Millipore division and Sysmex partnered to jointly develop EMD Millipore's Amnis imaging flow cytometry...

...develop a production platform for viral vectors with improved digestion of DNA impurities. The EMD Millipore Corp....
...develop a product with a "human liver like" phenotype for early stage toxicity testing. EMD Millipore...

...The Carlyle Group acquires the business, expected in mid-2014, formerly president, CEO and chairman of Millipore Corp....

...Merck's EMD Millipore Corp. division received a non-exclusive, worldwide license to develop and commercialize an induced pluripotent...
...portfolio for research applications from the university's technology transfer arm, iPS Academia Japan Inc. EMD Millipore...

...Ark Therapeutics and Merck's EMD Millipore Corp. division signed a non-binding letter of intent to partner for...
...manufacturing facility. The partners also plan to establish a suite at the facility with EMD Millipore's...